| Health / Medical Topics |
Dendritic Cell-Autologous Lung Tumor Vaccine
A cancer vaccine consisting of lymphocytes harvested from a patient with lung cancer and induced to become antigen-presenting cells (APCs) known as dendritic cells. The dendritic cells are transduced with the gene encoding an antigen specific to the patient's cancer and then returned to the patient. In the host, the altered cells stimulate the immune system to mount a primary T cell response against lung tumor cells expressing the target antigen. Dendritic cell-autologous lung tumor vaccines have been investigated for use in cancer immunotherapy. (NCI Thesaurus)
YOU MAY ALSO LIKE
A vaccine made of antigens and dendritic antigen-presenting cells (APCs).
A dendritic cell neoplasm that does not fall into well-defined categories or shows hybrid features.
A vaccine composed of dendritic cells pulsed with peptide epitopes that stimulate cytotoxic T lymphocyte anti-tumor activity.
A vaccine composed of dendritic cells pulsed with tumor cells lysates that stimulate a potent and specific cell mediated anti-tumor immune…
While T cells and B cells carry out the actions of antigen-specific immune responses, antigen-presenting cells called dendritic cells are required for…
A special type of immune cell that is found in tissues, such as the skin, and boosts immune responses by showing antigens…
